Clinical Outcomes of Open Flap Debridement with Metronidazole-Infused Titanium Platelet-Rich Fibrin versus Titanium Platelet-Rich Fibrin Alone: A Randomized Clinical Trial
Authors
Professor, Department of Periodontology and Oral Implantology, SMBT Dental College and Hospital, Sangamner (India)
Post Graduate, Department of Periodontology and Oral Implantology, SMBT Dental College and Hospital, Sangamner (India)
Post Graduate, Department of Periodontology and Oral Implantology, SMBT Dental College and Hospital, Sangamner (India)
Private Practitioner, Periodontist, Ace Dental Care, Pune (India)
Article Information
DOI: 10.51244/IJRSI.2026.1306000113
Subject Category: Microbiology
Volume/Issue: 13/6 | Page No: 1542-1550
Publication Timeline
Submitted: 2026-06-05
Accepted: 2026-06-10
Published: 2026-06-25
Abstract
Background: Residual periodontal pockets following conventional periodontal therapy may continue to harbor pathogenic microorganisms and compromise healing. Metronidazole is an effective antimicrobial agent against anaerobic periodontal pathogens, while Titanium-Platelet Rich Fibrin (T-PRF) provides a biologically active scaffold that promotes periodontal regeneration. This study evaluated the clinical efficacy of Metronidazole-infused T-PRF as an adjunct to open flap debridement (OFD) in the management of periodontal pockets.
Materials and Methods: Thirty patients diagnosed with Stage III–IV periodontitis presenting with residual periodontal pockets (PPD ≥5 mm) were enrolled in this single-blinded randomized clinical trial and allocated into two groups (n=15 each). The test group received OFD with Metronidazole-infused T-PRF, while the control group received OFD with T-PRF alone. Plaque Index (PI), Gingival Index (GI), Probing Pocket Depth (PPD), and Relative Clinical Attachment Level (RCAL) were recorded at baseline, 3 months, and 6 months postoperatively.
Results: Both groups demonstrated significant improvements in all clinical parameters from baseline to 6 months (p<0.001). The test group showed greater reductions in PPD (2.2 ± 0.6 mm) compared with the control group (1.8 ± 0.7 mm), although the difference was not statistically significant (p>0.05). RCAL gain was significantly greater in the Metronidazole-infused T-PRF group (2.3 ± 0.6 mm) than in the T-PRF group (1.7 ± 0.7 mm) (p<0.05). No significant intergroup differences were observed for PI and GI.
Conclusion: Both T-PRF and Metronidazole-infused T-PRF used in conjunction with OFD resulted in significant clinical improvements. However, Metronidazole-infused T-PRF demonstrated superior clinical attachment gain, suggesting that incorporation of metronidazole into the T-PRF matrix may enhance periodontal healing and improve treatment outcomes in periodontal pocket therapy.
Keywords
Periodontitis, Titanium-Platelet Rich Fibrin, T-PRF, Metronidazole, Open Flap Debridement, Periodontal Pockets.
Downloads
References
1. Bennardo F, Gallelli L, Palleria C, Colosimo M, Fortunato L, De Sarro G, Giudice A. Can platelet-rich fibrin act as a natural carrier for antibiotics delivery? A proof-of-concept study for oral surgical procedures. BMC Oral Health. 2023 Mar 9;23(1):134. https://doi.org/10.1186/s12903-023-02814-5 [Google Scholar] [Crossref]
2. Caffesse RG, Sweeney PL, Smith BA. Scaling and root planing with and without periodontal flap surgery. Journal of Clinical Periodontology. 1986 Mar;13(3):205-10. https://doi.org/10.1111/j.1600-051X.1986.tb01461.x [Google Scholar] [Crossref]
3. Chatterjee A, Pradeep AR, Garg V, Yajamanya S, Ali MM, Priya VS. Treatment of periodontal intrabony defects using autologous platelet‐rich fibrin and titanium platelet‐rich fibrin: a randomized, clinical, comparative study. Journal of Investigative and Clinical Dentistry. 2017 Aug;8(3):e12231. https://doi.org/10.1111/jicd.12231 [Google Scholar] [Crossref]
4. Choukroun J, Adda F, Schoeffler C, Vervelle AP. Une opportunité en paro-implantologie: le PRF. Implantodontie.2001Jan1;42(55):e62. https://www.researchgate.net/publication/284049099_Une_opportunit_en_paro-implantologie_Le_PRF [Google Scholar] [Crossref]
5. Cobb CM. Clinical significance of non‐surgical periodontal therapy: an evidence‐based perspective of scaling and root planing. Journal of Clinical Periodontology. 2002 May;29:22-32. https://doi.org/10.1034/j.1600-051X.29.s2.4.x [Google Scholar] [Crossref]
6. Drisko CH. Nonsurgical periodontal therapy. Periodontology 2000. 2001 Feb 1;25(1). https://doi.org/10.1034/j.1600-0757.2001.22250106.x [Google Scholar] [Crossref]
7. Ercan E, Suner SS, Silan C, Yilmaz S, Siddikoglu D, Sahiner N, Tunali M. Titanium platelet–rich fibrin (T-PRF) as high-capacity doxycycline delivery system. Clinical Oral Investigations. 2022 Aug;26(8):5429-38. https://doi.org/10.1007/s00784-022-04510-0 [Google Scholar] [Crossref]
8. Feres M, Figueiredo LC, Soares GM, Faveri M. Systemic antibiotics in the treatment of periodontitis. Periodontology 2000. 2015 Feb;67(1):131-86. https://doi.org/10.1111/prd.12075 [Google Scholar] [Crossref]
9. Gasparro R, Di Spirito F, Campana MD, Sammartino G, Di Lauro AE. The role of autologous platelet concentrates as a local antibiotic delivery system: a systematic scoping review. Antibiotics. 2024 Sep 6;13(9):856. https://doi.org/10.3390/antibiotics13090856 [Google Scholar] [Crossref]
10. Goodson JM. Antimicrobial strategies for treatment of periodontal diseases. Periodontology 2000. 1994 Jun;5(1):142-68. https://doi.org/10.1111/j.1600-0757.1994.tb00022.x [Google Scholar] [Crossref]
11. Heitz‐Mayfield LJ, Lang NP. Surgical and nonsurgical periodontal therapy. Learned and unlearned concepts. Periodontology 2000. 2013 Jun;62(1):218-31. https://doi.org/10.1111/prd.12008 [Google Scholar] [Crossref]
12. Indurkar MS, Purohit JN. Titanium platelet-rich fibrin (T-PRF) as doxycycline delivery system: an in-vitro study. Int J Oral Health Dent. 2024;10:91-4. https://doi.org/10.18231/j.ijohd.2024.019 [Google Scholar] [Crossref]
13. Löe H, Silness J. Periodontal disease in pregnancy I. Prevalence and severity. Acta Odontologica Scandinavica. 1963 Jan 1;21(6):533-51. https://doi.org/10.3109/00016356309011240 [Google Scholar] [Crossref]
14. Miron RJ, Choukroun J. Platelet Rich Fibrin in Regenerative Dentistry. Hoboken: Wiley Online Library; 2017. https://doi.org/10.1002/9781119406792 [Google Scholar] [Crossref]
15. Polak D, Clemer‐Shamai N, Shapira L. Incorporating antibiotics into platelet‐rich fibrin: a novel antibiotics slow‐release biological device. Journal of Clinical Periodontology. 2019 Feb;46(2):241-7. https://doi.org/10.1111/jcpe.13063 [Google Scholar] [Crossref]
16. Rams TE, Slots J. Local delivery of antimicrobial agents in the periodontal pocket. Periodontology 2000. 1996 Feb;10(1):139-59. https://doi.org/10.1111/j.1600-0757.1996.tb00072.x [Google Scholar] [Crossref]
17. Ravi S, Santhanakrishnan M. Mechanical, chemical, structural analysis and comparative release of PDGF-AA from L-PRF, A-PRF and T-PRF—an in vitro study. Biomaterials Research. 2020 Sep 11;24(1):16. https://doi.org/10.1186/s40824-020-00193-4 [Google Scholar] [Crossref]
18. Silness J, Löe H. Periodontal disease in pregnancy II. Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica. 1964 Jan 1;22(1):121-35. https://doi.org/10.3109/00016356408993968 [Google Scholar] [Crossref]
19. Thamaraiselvan M, Jayakumar ND. Efficacy of injectable platelet-rich fibrin (i-PRF) as a novel vehicle for local drug delivery in non-surgical periodontal pocket therapy: A randomized controlled clinical trial. Journal of Advanced Periodontology & Implant Dentistry. 2024 Sep 11;16(2):94. https://doi.org/10.34172/japid.2024.021 [Google Scholar] [Crossref]
20. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. Journal of Periodontology. 2018 Jun;89:S159-72. https://doi.org/10.1002/JPER.18-0006 [Google Scholar] [Crossref]
21. Tunalı M, Özdemir H, Küçükodacı Z, Akman S, Fıratlı E. In vivo evaluation of titanium-prepared platelet-rich fibrin (T-PRF): a new platelet concentrate. British Journal of Oral and Maxillofacial Surgery. 2013 Jul 1;51(5):438-43. https://doi.org/10.1016/j.bjoms.2012.08.003 [Google Scholar] [Crossref]
22. Tunalı M, Özdemir H, Küçükodacı Z, Akman S, Yaprak E, Toker H, Fıratlı E. A novel platelet concentrate: titanium‐prepared platelet‐rich fibrin. BioMed Research International. 2014;2014(1):209548. https://doi.org/10.1155/2014/209548 [Google Scholar] [Crossref]
Metrics
Views & Downloads
Similar Articles
- Quantitative Assessment of Serum C - Reactive Protein Levels among Smokers and Non Smokers
- Extraction and Characterization of Eco-Friendly Hair Dye from Agricultural Waste: A Study on Coconut Husk
- Intermittent Preventive Treatment among Pregnant Women Attending a Tertiary Healthcare Facility in Jos, North Central Nigeria: Adherence Patterns and Preliminary Assessment of Associated Factors
- Assessment Of Degradative Potentials Of Bacteria Isolated From Palm Oil-Polluted Site Using Spectrophotometric Method
- An Analysis of Machine and Deep Learning Insights on the Use of Artificial Intelligence in Oral and Maxillofacial Pathology